India’s new guidelines for Covid-19 Treatment: Too Little Too Late? l IndiaSpend | Editorji
  1. home
  2. > IndiaSpend
  3. > India’s new guidelines for Covid-19 Treatment: Too Little Too Late?
prev icon/Assets/images/svg/play_white.svgnext button of playermute button of playermaximize icon
mute icontap to unmute
video play icon
00:00/00:00
prev iconplay paus iconnext iconmute iconmaximize icon
close_white icon

India’s new guidelines for Covid-19 Treatment: Too Little Too Late?

Jun 10, 2021 16:59 IST

 India on June 7 issued a new clinical protocol for Covid19 treatment wherein commonly used drugs like hydroxychloroquine (HCQ), ivermectin and antiviral drug favipiravir were dropped. What do clinical practitioners think about the move? IndiaSpend's Govindraj Ethiraj speaks to Dr. Lancelot Pinto, Consultant Pulmonologist, Hinduja Hospital and Dr. Sumit Ray, Head of Department of Critical Care, Holy Family Hospitals.

Dr. Sumit Ray says the new guidelines are more appropriate and it should have been updated earlier. Dr. Ray adds that we need to have the courage to question political decision makers in making guidelines. Dr. Lancelot Pinto suggests that a committee can meet once in every 15 days to discuss latest development and update the guidelines if necessary. Watch the full interview!

India’s new guidelines for Covid-19 Treatment: Too Little Too Late?

1/3

India’s new guidelines for Covid-19 Treatment: Too Little Too Late?

‘We were caught unawares by sudden monsoon disease outbreaks in UP’

2/3

‘We were caught unawares by sudden monsoon disease outbreaks in UP’

What could endemic Covid-19 look like?

3/3

What could endemic Covid-19 look like?